Balaton

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator controlled Study To Evaluate The Efficacy And Safety Of Faricimab In Patients With Macular Edema Secondary To Branch Retinal Vein Occlusion

Study Type  : Interventional  (Clinical Trial)
Actual Enrollment  : 553 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion
Actual Study Start Date  : March 2, 2021
Estimated Primary Completion Date  : July 15, 2022
Estimated Study Completion Date  : June 15, 2023

Related Publications

Our Affiliates